Adiponectin has been associated with common metabolic disorders. The current study was conducted to measure and compare levels of adiponectin with obesity, type 2 diabetes mellitus (T2DM) and gender in Punjabi subjects from Faisalabad, Pakistan. Serum adiponectin was measured by enzyme-linked immunosorbent assay (ELISA) along with measurements of some clinically important analytes (fasting blood glucose, cholesterol, triglycerides) as well as body mass index (BMI) in 80 subjects. The main results were significantly (p<0.003) decreased serum adiponectin level in T2DM patients (n=40) compared to non-diabetic controls (n=40). In obese subjects, (n=40) also, there was a decrease, but it was not significant. Adiponectin levels in the subgroups of diabetic and obese patients were also observed, but no significant gender-based differences were found.
|Number of pages||3|
|Journal||JPMA. The Journal of the Pakistan Medical Association|
|Publication status||Published - 1 Oct 2014|
- Type 2 Diabetes Mellitus